相关实验视频

Updated: Sep 13, 2025

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

铜离子体通过DLAT-cuprotosis提高了西斯的效率

Jun Tang¹, Lingling Zhao¹, Xiujuan Qiu¹

¹Department of oncology, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Jiefang Road 15, Xiangyang 441000, PR China.

Toxicology and applied pharmacology

|August 1, 2025

概括

二醇胺S-乙转移酶 (DLAT) 是乳腺癌进展和化学抵抗的一个关键因素. 向DLAT和诱导cuproptosis可能为三阴性乳腺癌 (TNBC) 提供新的治疗策略.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
癌症研究癌症研究

背景情况:

三阴性乳腺癌 (TNBC) 缺乏有效的治疗方法.
与cuproptosis相关的基因 (CRG) 影响乳腺癌的进展.
在乳腺癌中二利胺S-乙转移酶 (DLAT) 的作用尚不清楚.

研究的目的:

研究DLAT在乳腺癌中的作用和机制.
探索DLAT作为治疗标和生物标记物的潜力.

主要方法:

对TCGA-BRCA和HAP数据库进行DLAT表达的分析.
不同基因和丰富分析.
在乳腺癌细胞中进行DLAT敲除实验.
使用ES-Cu. 的药物敏感性测定和异种移植模型.

主要成果:

乳腺瘤中DLAT表达发生变化,与预后有关.
较高的DLAT参与细胞循环,衰老和p53通路,与免疫透相关.
消除DLAT可以抑制核武器的扩散,迁移和入侵.
ES-Cu通过诱导DLAT寡合化,cuproptosis和增加ROS来逆转西斯普拉丁耐药性.

结论:

DLAT在乳腺癌的进展和化学抵抗方面发挥着重要作用.
DLAT是免疫治疗的潜在生物标志物,也是cuproptosis的调解者.
针对DLAT提供了一个有希望的策略,以提高乳腺癌化疗的疗效.

关键词:

乳腺癌是什么? 乳腺癌是什么化疗化疗是一种化学疗法.铜离子体是一种铜离子体.这就是Cuprotosis的Cuprotosis.DLAT DLAT 这是一个很好的方法.免疫系统的透.

更多相关视频

Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance

Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance

Published on: December 13, 2015

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

相关概念视频

Extraction: Advanced Methods

Extraction: Advanced Methods

Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...